During the past decade, Nasz Lekarz Przychodnie Medyczne conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 34 clinical trials were completed, i.e. on average, 97.1% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 18 clinical trials were completed. i.e. 128.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nasz Lekarz Przychodnie Medyczne" #1 sponsor was "Pfizer" with 19 trials, followed by "Galapagos NV" with 5 trials sponsored, "Boehringer Ingelheim" with 4 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored and "Bristol-Myers Squibb" with 3 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nasz Lekarz Przychodnie Medyczne" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "IQVIA Pvt. Ltd" with 1 trials as a collaborator and "Incyte Corporation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Nasz Lekarz Przychodnie Medyczne" are "Rheumatoid Arthritis" (12 trials), "Arthritis, Rheumatoid" (5 trials), "Arthritis, Psoriatic" (4 trials), "Psoriatic Arthritis" (4 trials) and "Psoriasis" (3 trials). Many other conditions were trialed in "Nasz Lekarz Przychodnie Medyczne" in a lesser frequency.

Most popular intervention types in "Nasz Lekarz Przychodnie Medyczne" are "Drug" (49 trials), "Biological" (13 trials) and "Other" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "PF-06700841" (4 trials), "Guselkumab" (3 trials), "filgotinib" (3 trials) and "Adalimumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Nasz Lekarz Przychodnie Medyczne" are 56 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Nasz Lekarz Przychodnie Medyczne". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 43 completed trials in Nasz Lekarz Przychodnie Medyczne, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Nasz Lekarz Przychodnie Medyczne, 3 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 0 trials that are defined as “Not Applicable".